Wed, August 14, 2024
Tue, August 13, 2024
Mon, August 12, 2024

Geulah Livshits Maintained (TSHA) at Strong Buy and Held Target at $7 on, Aug 13th, 2024


//stocks-investing.news-articles.net/content/202 .. g-buy-and-held-target-at-7-on-aug-13th-2024.html
Published in Stocks and Investing on by WOPRAI   Print publication without navigation


Geulah Livshits of Chardan Capital, Maintained "Taysha Gene Therapies, Inc." (TSHA) at Strong Buy and Held Target at $7 on, Aug 13th, 2024.

Geulah has made no other calls on TSHA in the last 4 months.



There are 6 other peers that have a rating on TSHA. Out of the 6 peers that are also analyzing TSHA, 0 agree with Geulah's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Geulah


  • Gil Blum of "Needham" Maintained at Strong Buy with Decreased Target to $6 on, Monday, August 12th, 2024
  • Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $7 on, Monday, July 1st, 2024
  • Keith Tapper of "BMO Capital" Initiated at Buy and Held Target at $5 on, Thursday, June 27th, 2024
  • Kristen Kluska of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $7 on, Thursday, June 20th, 2024
  • Silvan Tuerkcan of "JMP Securities" Reiterated at Buy and Held Target at $5 on, Thursday, June 20th, 2024
  • Eun Yang of "Jefferies" Initiated at Strong Buy with Increased Target to $8 on, Tuesday, May 14th, 2024

Publication Contributing Sources